Quintanilha, Julia C.F.Wang, JinSibley, Alexander B.Jiang, ChenEtheridge, Amy S.Shen, FeiJiang, GuanglongMulkey, FloraPatel, Jai N.Hertz, Daniel L.Dees, Elizabeth ClaireMcLeod, Howard L.Bertagnolli, MonicaRugo, HopeKindler, Hedy L.Kelly, William KevinRatain, Mark J.Kroetz, Deanna L.Owzar, KourosSchneider, Bryan P.Lin, DanyuInnocenti, Federico2023-05-152023-05-152022Quintanilha JCF, Wang J, Sibley AB, et al. Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients. Br J Cancer. 2022;126(1):162. doi:10.1038/s41416-021-01617-1https://hdl.handle.net/1805/32960Correction to: British Journal of Cancer 10.1038/s41416-021-01557-w, published online 06 October 2021 The original version of this article unfortunately contained a mistake in an author affiliation. Dr. Kouros Owzar was listed as “Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA”, when it should be “Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA”. The original article has been corrected.en-USPublisher PolicyCancer geneticsPredictive markersArticle